Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth ▾	Diluted EPS
ONCO	Onconetix, Inc. Manufacturing · Year ended 2025-12-31 · USD	$815.4K	-$14.03M	n/m	-89.0%	-67.7%	-$16.56
INO	Inovio Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$65.3K	-$84.95M	n/m	-352.5%	-70.0%	-$1.81
ROIV	Roivant Sciences Ltd. Manufacturing · Year ended 2026-03-31 · USD	$8.26M	-$299.77M	n/m	-6.6%	-71.6%	-$0.54
BTAIQ	BioXcel Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$642.0K	-$69.90M	n/m	n/a	-71.7%	-$5.73
WHWK	Whitehawk Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.14M	-$20.60M	-288.3%	-15.1%	-72.5%	-$0.33
IBIO	iBio, Inc. Manufacturing · Year ended 2026-06-30 · USD	$100.0K	-$33.04M	n/m	-38.6%	-75.0%	-$0.32
LPCN	Lipocine Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.98M	-$9.63M	-487.1%	-66.5%	-82.3%	-$1.69
STTK	Shattuck Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.00M	-$48.81M	n/m	-59.2%	-82.5%	-$0.70
LSTA	Lisata Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$170.0K	-$16.59M	n/m	-111.7%	-83.0%	-$1.91
AVTX	Avalo Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$59.0K	-$78.26M	n/m	-94.2%	-86.6%	-$5.84
TRDA	Entrada Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$25.42M	-$143.75M	-565.5%	-47.0%	-87.9%	-$3.47
PTGX	Protagonist Therapeutics, Inc Manufacturing · Year ended 2025-12-31 · USD	$46.02M	-$130.15M	-282.8%	-21.2%	-89.4%	-$2.05
NEUP	Neuphoria Therapeutics Inc. Manufacturing · Year ended 2026-06-30 · USD	$1.17M	-$13.45M	n/m	-54.7%	-92.5%	-$3.06
RNAC	Cartesian Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.80M	-$130.30M	n/m	n/a	-92.8%	-$5.02
PRTA	Prothena Corp Public Ltd Co Manufacturing · Year ended 2025-12-31 · USD	$9.68M	-$244.09M	n/m	-87.0%	-92.8%	-$4.53
ADTX	Aditxt, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.2K	-$43.10M	n/m	-768.3%	-97.6%	-$1153.83
HCWB	HCW Biologics Inc. Manufacturing · Year ended 2025-12-31 · USD	$54.2K	-$7.96M	n/m	-287.9%	-97.9%	-$10.63
SLN	Silence Therapeutics plc Manufacturing · Year ended 2025-12-31 · USD	$559.0K	-$88.61M	n/m	-142.2%	-98.7%	-$0.63
CNTB	Connect Biopharma Holdings Ltd Manufacturing · Year ended 2025-12-31 · USD	$64.0K	-$55.48M	n/m	-132.2%	-99.8%	-$1.00
AMLX	Amylyx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$144.74M	n/a	-47.4%	-100.0%	-$1.53
AZTR	Azitra, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$10.96M	n/a	-288.2%	-100.0%	-$2.25
CAPR	Capricor Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$105.04M	n/a	-34.4%	-100.0%	-$2.26
CNBX	CNBX Pharmaceuticals Inc. Manufacturing · Year ended 2025-08-31 · USD	$0	-$314.0K	n/a	n/a	-100.0%	$0.00
FULC	Fulcrum Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$74.88M	n/a	-21.5%	-100.0%	-$1.18
IXHL	Incannex Healthcare Inc. Manufacturing · Year ended 2026-06-30 · USD	$0	-$19.30M	n/a	-28.6%	-100.0%	-$1.66

Rows per page: 2550 100